{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:54:02Z","timestamp":1782219242457,"version":"3.54.5"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12209-8","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:27:15Z","timestamp":1782217635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor-adapted regulatory T cells: Molecular reprogramming, immune suppression, and therapeutic targeting in cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Mohammad","family":"Fayyad-Kazan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"12209_CR1","doi-asserted-by":"publisher","unstructured":"Romano M, Fanelli G, Albany CJ et al (2019) Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.00043","DOI":"10.3389\/fimmu.2019.00043"},{"key":"12209_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","volume":"56","author":"S Dikiy","year":"2023","unstructured":"Dikiy S, Rudensky AY (2023) Principles of regulatory T cell function. Immunity 56:240\u2013255. https:\/\/doi.org\/10.1016\/j.immuni.2023.01.004","journal-title":"Immunity"},{"key":"12209_CR3","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi S, Sakaguchi N, Asano M et al (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor \u03b1-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151\u20131164. https:\/\/doi.org\/10.4049\/jimmunol.155.3.1151","journal-title":"J Immunol"},{"key":"12209_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Christie J, Ramsdell F et al (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20\u201321. https:\/\/doi.org\/10.1038\/83713","journal-title":"Nat Genet"},{"key":"12209_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2889","volume":"10","author":"JH Buckner","year":"2010","unstructured":"Buckner JH (2010) Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 10:849\u2013859. https:\/\/doi.org\/10.1038\/nri2889","journal-title":"Nat Rev Immunol"},{"key":"12209_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-cancerbio-030419-033428","volume":"4","author":"G Plitas","year":"2020","unstructured":"Plitas G, Rudensky AY (2020) Regulatory T Cells in Cancer. Annu Rev Cancer Biol 4:459\u2013477. https:\/\/doi.org\/10.1146\/annurev-cancerbio-030419-033428","journal-title":"Annu Rev Cancer Biol"},{"key":"12209_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nri3667","volume":"14","author":"L Klein","year":"2014","unstructured":"Klein L, Kyewski B, Allen PM, Hogquist KA (2014) Positive and negative selection of the T cell repertoire: what thymocytes see (and don\u2019t see). Nat Rev Immunol 14:377\u2013391. https:\/\/doi.org\/10.1038\/nri3667","journal-title":"Nat Rev Immunol"},{"key":"12209_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","volume":"30","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz SZ, Lu LF, Rudensky AY (2012) Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30:531\u2013564. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141623","journal-title":"Annu Rev Immunol"},{"key":"12209_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nri3155","volume":"12","author":"CS Hsieh","year":"2012","unstructured":"Hsieh CS, Lee HM, Lio CWJ (2012) Selection of regulatory T cells in the thymus. Nat Rev Immunol 12:157\u2013167. https:\/\/doi.org\/10.1038\/nri3155","journal-title":"Nat Rev Immunol"},{"key":"12209_CR10","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"WJ Chen","year":"2003","unstructured":"Chen WJ, Jin W, Hardegen N et al (2003) Conversion of peripheral CD4\u2009+\u2009CD25- naive T cells to CD4\u2009+\u2009CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198:1875\u20131886. https:\/\/doi.org\/10.1084\/jem.20030152","journal-title":"J Exp Med"},{"key":"12209_CR11","doi-asserted-by":"publisher","first-page":"0169","DOI":"10.1371\/journal.pbio.0050038","volume":"5","author":"S Floess","year":"2007","unstructured":"Floess S, Freyer J, Siewert C et al (2007) Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5:0169\u20130178. https:\/\/doi.org\/10.1371\/journal.pbio.0050038","journal-title":"PLoS Biol"},{"key":"12209_CR12","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","volume":"184","author":"AM Thornton","year":"2010","unstructured":"Thornton AM, Korty PE, Tran DQ et al (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3\u2009+\u2009T regulatory cells. J Immunol 184:3433\u20133441. https:\/\/doi.org\/10.4049\/jimmunol.0904028","journal-title":"J Immunol"},{"key":"12209_CR13","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4\u2009+\u2009CD25+ regulatory T cells. Nat Immunol 4:986\u2013992. https:\/\/doi.org\/10.1038\/ni904","journal-title":"Nat Immunol"},{"key":"12209_CR14","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ni1536","volume":"8","author":"P Pandiyan","year":"2007","unstructured":"Pandiyan P, Zheng L, Ishihara S et al (2007) CD4\u2009+\u2009CD25+Foxp3\u2009+\u2009regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4\u2009+\u2009T cells. Nat Immunol 8:1353\u20131362. https:\/\/doi.org\/10.1038\/ni1536","journal-title":"Nat Immunol"},{"key":"12209_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.1160062","volume":"322","author":"K Wing","year":"2008","unstructured":"Wing K, Onishi Y, Prieto-Martin P et al (2008) CTLA-4 control over Foxp3\u2009+\u2009regulatory T cell function. Science 322:271\u2013275. https:\/\/doi.org\/10.1126\/science.1160062","journal-title":"Science"},{"key":"12209_CR16","doi-asserted-by":"publisher","first-page":"1530301","DOI":"10.3389\/fimmu.2025.1530301","volume":"16","author":"P Shi","year":"2025","unstructured":"Shi P, Yu Y, Xie H et al (2025) Recent advances in regulatory immune cells: exploring the world beyond Tregs. Front Immunol 16:1530301. https:\/\/doi.org\/10.3389\/fimmu.2025.1530301","journal-title":"Front Immunol"},{"key":"12209_CR17","doi-asserted-by":"publisher","unstructured":"Zhang A, Fan T, Liu Y et al (2024) Regulatory T cells in immune checkpoint blockade antitumor therapy. Molecular Cancer 23:1 23:251-. https:\/\/doi.org\/10.1186\/s12943-024-02156-y","DOI":"10.1186\/s12943-024-02156-y"},{"key":"12209_CR18","doi-asserted-by":"publisher","first-page":"1110325","DOI":"10.3389\/fimmu.2023.1110325","volume":"14","author":"X Jiang","year":"2023","unstructured":"Jiang X, Wu X, Xiao Y et al (2023) The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy. Front Immunol 14:1110325. https:\/\/doi.org\/10.3389\/fimmu.2023.1110325","journal-title":"Front Immunol"},{"key":"12209_CR19","doi-asserted-by":"publisher","first-page":"1511671","DOI":"10.3389\/fimmu.2025.1511671","volume":"16","author":"MS Fisher","year":"2025","unstructured":"Fisher MS, Sennikov SV (2025) T-regulatory cells for the treatment of autoimmune diseases. Front Immunol 16:1511671. https:\/\/doi.org\/10.3389\/fimmu.2025.1511671","journal-title":"Front Immunol"},{"key":"12209_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms25021205","volume":"25","author":"N Aloi","year":"2024","unstructured":"Aloi N, Drago G, Ruggieri S et al (2024) Extracellular Vesicles and Immunity: At the Crossroads of Cell Communication. Int J Mol Sci 2024 25:25. https:\/\/doi.org\/10.3390\/ijms25021205","journal-title":"Int J Mol Sci 2024"},{"key":"12209_CR21","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/ijms27041676","volume":"27","author":"D Primorac","year":"2026","unstructured":"Primorac D, Brlek P, Buli\u0107 L et al (2026) Therapeutic Potential of Extracellular Vesicles: From Biogenesis, Isolation and Molecular Characterization to Addressing Translational Gaps and Regulatory Barriers. Int J Mol Sci 27:1676. https:\/\/doi.org\/10.3390\/ijms27041676","journal-title":"Int J Mol Sci"},{"key":"12209_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3390\/biology15030254","volume":"15","author":"H Chang","year":"2026","unstructured":"Chang H, Wang Y, Gao L, Zheng SJ (2026) Beyond Conventional Transcriptional Regulation Function: FOXP3 as an Integrative Hub for Chromatin Interactions and Protein Complexes in Immune Regulation. Biology (Basel) 15:254. https:\/\/doi.org\/10.3390\/biology15030254","journal-title":"Biology (Basel)"},{"key":"12209_CR23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","volume":"39","author":"P Georgiev","year":"2019","unstructured":"Georgiev P, Charbonnier LM, Chatila TA (2019) Regulatory T Cells: the Many Faces of Foxp3. J Clin Immunol 39:623\u2013640. https:\/\/doi.org\/10.1007\/s10875-019-00684-7","journal-title":"J Clin Immunol"},{"key":"12209_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","volume":"50","author":"JB Wing","year":"2019","unstructured":"Wing JB, Tanaka A, Sakaguchi S (2019) Human FOXP3\u2009+\u2009Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer. Immunity 50:302\u2013316. https:\/\/doi.org\/10.1016\/j.immuni.2019.01.020","journal-title":"Immunity"},{"key":"12209_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2006.05.042","volume":"126","author":"Y Wu","year":"2006","unstructured":"Wu Y, Borde M, Heissmeyer V et al (2006) FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT. Cell 126:375\u2013387. https:\/\/doi.org\/10.1016\/j.cell.2006.05.042","journal-title":"Cell"},{"key":"12209_CR26","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/ni.1795","volume":"10","author":"D Rudra","year":"2009","unstructured":"Rudra D, Egawa T, Chong MMW et al (2009) Runx-CBF\u03b2 complexes control Foxp3 expression in regulatory T cells. Nat Immunol 10:1170. https:\/\/doi.org\/10.1038\/ni.1795","journal-title":"Nat Immunol"},{"key":"12209_CR27","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","volume":"38","author":"N Ohkura","year":"2013","unstructured":"Ohkura N, Kitagawa Y, Sakaguchi S (2013) Development and Maintenance of Regulatory T cells. Immunity 38:414\u2013423. https:\/\/doi.org\/10.1016\/j.immuni.2013.03.002","journal-title":"Immunity"},{"key":"12209_CR28","doi-asserted-by":"publisher","unstructured":"He M, Feng Y (2025) Elusive modes of Foxp3 activity in versatile regulatory T cells. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1533823","DOI":"10.3389\/fimmu.2024.1533823"},{"key":"12209_CR29","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2015.04.015","volume":"42","author":"JB Spangler","year":"2015","unstructured":"Spangler JB, Tomala J, Luca VC et al (2015) Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms. Immunity 42:815\u2013825. https:\/\/doi.org\/10.1016\/j.immuni.2015.04.015","journal-title":"Immunity"},{"key":"12209_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4049\/jimmunol.178.1.280","volume":"178","author":"MA Burchill","year":"2007","unstructured":"Burchill MA, Yang J, Vogtenhuber C et al (2007) IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3\u2009+\u2009regulatory T cells. J Immunol 178:280\u2013290. https:\/\/doi.org\/10.4049\/jimmunol.178.1.280","journal-title":"J Immunol"},{"key":"12209_CR31","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nri3108","volume":"11","author":"LSK Walker","year":"2011","unstructured":"Walker LSK, Sansom DM (2011) The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat Rev Immunol 11:852\u2013863. https:\/\/doi.org\/10.1038\/nri3108","journal-title":"Nat Rev Immunol"},{"key":"12209_CR32","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/ni1003","volume":"4","author":"F Fallarino","year":"2003","unstructured":"Fallarino F, Grohmann U, Hwang KW et al (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4:1206\u20131212. https:\/\/doi.org\/10.1038\/ni1003","journal-title":"Nat Immunol"},{"key":"12209_CR33","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2217\/imt.14.84","volume":"6","author":"NM Chapman","year":"2014","unstructured":"Chapman NM, Chi H (2014) mTOR signaling, Tregs and immune modulation. Immunotherapy 6:1295. https:\/\/doi.org\/10.2217\/imt.14.84","journal-title":"Immunotherapy"},{"key":"12209_CR34","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.1073\/pnas.0800928105","volume":"105","author":"S Sauer","year":"2008","unstructured":"Sauer S, Bruno L, Hertweck A et al (2008) T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 105:7797\u20137802. https:\/\/doi.org\/10.1073\/pnas.0800928105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12209_CR35","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1111\/j.1600-6143.2011.03963.x","volume":"12","author":"K Singh","year":"2012","unstructured":"Singh K, Kozyr N, Stempora L et al (2012) Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus. Am J Transplant 12:1441\u20131457. https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03963.x","journal-title":"Am J Transplant"},{"key":"12209_CR36","doi-asserted-by":"publisher","first-page":"1066375","DOI":"10.3389\/fimmu.2022.1066375","volume":"13","author":"MM Rodari","year":"2022","unstructured":"Rodari MM, Cerf-Bensussan N, Parlato M (2022) Dysregulation of the immune response in TGF-\u03b2 signalopathies. Front Immunol 13:1066375. https:\/\/doi.org\/10.3389\/fimmu.2022.1066375","journal-title":"Front Immunol"},{"key":"12209_CR37","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","volume":"134","author":"MO Li","year":"2008","unstructured":"Li MO, Flavell RA (2008) TGF-\u03b2: A Master of All T Cell Trades. Cell 134:392. https:\/\/doi.org\/10.1016\/j.cell.2008.07.025","journal-title":"Cell"},{"key":"12209_CR38","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.cell.2017.08.004","volume":"170","author":"Y Grinberg-Bleyer","year":"2017","unstructured":"Grinberg-Bleyer Y, Oh H, Desrichard A et al (2017) NF-\u03baB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer. Cell 170:1096\u20131108e13. https:\/\/doi.org\/10.1016\/j.cell.2017.08.004","journal-title":"Cell"},{"key":"12209_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","volume":"168","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Lenardo MJ, Baltimore D (2017) 30 Years of NF-\u03baB: A Blossoming of Relevance to Human Pathobiology. Cell 168:37\u201357. https:\/\/doi.org\/10.1016\/j.cell.2016.12.012","journal-title":"Cell"},{"key":"12209_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","volume":"21","author":"S Ma","year":"2024","unstructured":"Ma S, Ming Y, Wu J, Cui G (2024) Cellular metabolism regulates the differentiation and function of T-cell subsets. Cell Mol Immunol 21:419. https:\/\/doi.org\/10.1038\/s41423-024-01148-8","journal-title":"Cell Mol Immunol"},{"key":"12209_CR41","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng H, Yang K, Cloer C et al (2013) mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 499:485\u2013490. https:\/\/doi.org\/10.1038\/nature12297","journal-title":"Nature"},{"key":"12209_CR42","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41392-025-02326-4","volume":"10","author":"L Wang","year":"2025","unstructured":"Wang L, Liang Y, Zhao C et al (2025) Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential. Signal Transduct Target Ther 10:345. https:\/\/doi.org\/10.1038\/s41392-025-02326-4","journal-title":"Signal Transduct Target Ther"},{"key":"12209_CR43","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41388-020-1216-5","volume":"39","author":"TP Brown","year":"2020","unstructured":"Brown TP, Bhattacharjee P, Ramachandran S et al (2020) The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment. Oncogene 39:3292\u20133304. https:\/\/doi.org\/10.1038\/s41388-020-1216-5","journal-title":"Oncogene"},{"key":"12209_CR44","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MLJ Watson","year":"2021","unstructured":"Watson MLJ, Vignali PDA, Mullett SJ et al (2021) Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature 591:645\u2013651. https:\/\/doi.org\/10.1038\/s41586-020-03045-2","journal-title":"Nature"},{"key":"12209_CR45","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/ni.3799","volume":"18","author":"M Delacher","year":"2017","unstructured":"Delacher M, Imbusch CD, Weichenhan D et al (2017) Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues. Nat Immunol 18:1160\u20131172. https:\/\/doi.org\/10.1038\/ni.3799","journal-title":"Nat Immunol"},{"key":"12209_CR46","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.cell.2014.07.030","volume":"158","author":"X Li","year":"2014","unstructured":"Li X, Liang Y, Leblanc M et al (2014) Function of a foxp3 cis-element in protecting regulatory T cell identity. Cell 158:734\u2013748. https:\/\/doi.org\/10.1016\/j.cell.2014.07.030","journal-title":"Cell"},{"key":"12209_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cell.2012.06.053","volume":"151","author":"RM Samstein","year":"2012","unstructured":"Samstein RM, Arvey A, Josefowicz SZ et al (2012) Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151:153\u2013166. https:\/\/doi.org\/10.1016\/j.cell.2012.06.053","journal-title":"Cell"},{"key":"12209_CR48","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1182\/blood-2009-02-207118","volume":"115","author":"J Van Loosdregt","year":"2010","unstructured":"Van Loosdregt J, Vercoulen Y, Guichelaar T et al (2010) Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115:965\u2013974. https:\/\/doi.org\/10.1182\/blood-2009-02-207118","journal-title":"Blood"},{"key":"12209_CR49","doi-asserted-by":"publisher","first-page":"1695894","DOI":"10.3389\/fimmu.2025.1695894","volume":"16","author":"S Prasad","year":"2025","unstructured":"Prasad S, Adivikolanu H, Banerjee A et al (2025) The role of microRNAs and long non-coding RNAs in epigenetic regulation of T cells: implications for autoimmunity. Front Immunol 16:1695894. https:\/\/doi.org\/10.3389\/fimmu.2025.1695894","journal-title":"Front Immunol"},{"key":"12209_CR50","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","volume":"178","author":"PJ Murray","year":"2007","unstructured":"Murray PJ (2007) The JAK-STAT Signaling Pathway: Input. J Immunol References 178:2623\u20132629. https:\/\/doi.org\/10.4049\/jimmunol.178.5.2623","journal-title":"J Immunol References"},{"key":"12209_CR51","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","volume":"50","author":"W Ouyang","year":"2019","unstructured":"Ouyang W, O\u2019Garra A (2019) IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation. Immunity 50:871\u2013891. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.020","journal-title":"Immunity"},{"key":"12209_CR52","doi-asserted-by":"publisher","first-page":"1533335","DOI":"10.3389\/fimmu.2025.1533335","volume":"16","author":"F Sheng","year":"2025","unstructured":"Sheng F, Li M, Yu JM et al (2025) IL-33\/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential. Front Immunol 16:1533335. https:\/\/doi.org\/10.3389\/fimmu.2025.1533335","journal-title":"Front Immunol"},{"key":"12209_CR53","doi-asserted-by":"publisher","unstructured":"Qin D, Zhang Y, Shu P et al (2024) Targeting tumor-infiltrating tregs for improved antitumor responses. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1325946","DOI":"10.3389\/fimmu.2024.1325946"},{"key":"12209_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.it.2025.01.001","volume":"46","author":"Y Wen","year":"2025","unstructured":"Wen Y, Xia Y, Yang X et al (2025) CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells. Trends Immunol 46:153\u2013165. https:\/\/doi.org\/10.1016\/j.it.2025.01.001","journal-title":"Trends Immunol"},{"key":"12209_CR55","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","volume":"17","author":"B Allard","year":"2020","unstructured":"Allard B, Allard D, Buisseret L, Stagg J (2020) The adenosine pathway in immuno-oncology. Nat Rev Clin Oncol 17:611\u2013629. https:\/\/doi.org\/10.1038\/s41571-020-0382-2","journal-title":"Nat Rev Clin Oncol"},{"key":"12209_CR56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/imcb.12613","volume":"101","author":"V Malviya","year":"2023","unstructured":"Malviya V, Yshii L, Junius S et al (2023) Regulatory T-cell stability and functional plasticity in health and disease. Immunol Cell Biol 101:112\u2013129. https:\/\/doi.org\/10.1111\/imcb.12613","journal-title":"Immunol Cell Biol"},{"key":"12209_CR57","doi-asserted-by":"publisher","first-page":"e20230893","DOI":"10.1084\/jem.20230893","volume":"221","author":"B Shin","year":"2024","unstructured":"Shin B, Chang SJ, Macnabb BW, Rothenberg EV (2024) Transcriptional network dynamics in early T cell development. J Exp Med 221:e20230893. https:\/\/doi.org\/10.1084\/jem.20230893","journal-title":"J Exp Med"},{"key":"12209_CR58","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1126\/science.aaa9420","volume":"349","author":"E Sefik","year":"2015","unstructured":"Sefik E, Geva-Zatorsky N, Oh S et al (2015) Individual intestinal symbionts induce a distinct population of ROR\u03b3\u2009+\u2009regulatory T cells. Science 349:993. https:\/\/doi.org\/10.1126\/science.aaa9420","journal-title":"Science"},{"key":"12209_CR59","doi-asserted-by":"publisher","first-page":"1601756","DOI":"10.3389\/fimmu.2025.1601756","volume":"16","author":"H Xavier","year":"2025","unstructured":"Xavier H, Gireesh AGM, Thomas JA et al (2025) Chemokines: humble yet mighty players in the tumour microenvironment. Front Immunol 16:1601756. https:\/\/doi.org\/10.3389\/fimmu.2025.1601756","journal-title":"Front Immunol"},{"key":"12209_CR60","doi-asserted-by":"publisher","first-page":"1703211","DOI":"10.3389\/fimmu.2025.1703211","volume":"16","author":"P Basurto-Olvera","year":"2025","unstructured":"Basurto-Olvera P, Serrano H, Maldonado-Bernal C (2025) Regulatory T cells in cancer: from immunosuppression to therapeutic targeting. Front Immunol 16:1703211. https:\/\/doi.org\/10.3389\/fimmu.2025.1703211","journal-title":"Front Immunol"},{"key":"12209_CR61","doi-asserted-by":"publisher","unstructured":"Kidani Y, Nogami W, Yasumizu Y et al (2022) CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory. Proceedings of the National Academy of Sciences 119:e2114282119. https:\/\/doi.org\/10.1073\/pnas.2114282119","DOI":"10.1073\/pnas.2114282119"},{"key":"12209_CR62","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s12967-024-05518-8","volume":"22","author":"Q Chen","year":"2024","unstructured":"Chen Q, Shen M, Yan M et al (2024) Targeting tumor-infiltrating CCR8\u2009+\u2009regulatory T cells induces antitumor immunity through functional restoration of CD4\u2009+\u2009Tconvs and CD8\u2009+\u2009T cells in colorectal cancer. J Transl Med 22:709. https:\/\/doi.org\/10.1186\/s12967-024-05518-8","journal-title":"J Transl Med"},{"key":"12209_CR63","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","volume":"41","author":"C Tay","year":"2023","unstructured":"Tay C, Tanaka A, Sakaguchi S (2023) Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell 41:450\u2013465. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.014","journal-title":"Cancer Cell"},{"key":"12209_CR64","doi-asserted-by":"publisher","unstructured":"Shan F, Cillo AR, Cardello C et al (2023) Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells. Sci Immunol 8. https:\/\/doi.org\/10.1126\/sciimmunol.adf6717","DOI":"10.1126\/sciimmunol.adf6717"},{"key":"12209_CR65","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41388-025-03458-1","volume":"44","author":"J Saravia","year":"2025","unstructured":"Saravia J, Chi H (2025) Immunometabolism of regulatory T cells in cancer. Oncogene 44:2011\u20132024. https:\/\/doi.org\/10.1038\/s41388-025-03458-1","journal-title":"Oncogene"},{"key":"12209_CR66","doi-asserted-by":"publisher","unstructured":"Dykema AG, Zhang J, Cheung LS et al (2023) Lung tumor\u2013infiltrating Treg have divergent transcriptional profiles and function linked to checkpoint blockade response. Sci Immunol 8. https:\/\/doi.org\/10.1126\/sciimmunol.adg1487","DOI":"10.1126\/sciimmunol.adg1487"},{"key":"12209_CR67","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/nm.4086","volume":"22","author":"T Saito","year":"2016","unstructured":"Saito T, Nishikawa H, Wada H et al (2016) Two FOXP3\u2009+\u2009CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers. Nat Med 2016 22:6. https:\/\/doi.org\/10.1038\/nm.4086","journal-title":"Nat Med 2016"},{"key":"12209_CR68","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","volume":"26","author":"RJ Johnston","year":"2014","unstructured":"Johnston RJ, Comps-Agrar L, Hackney J et al (2014) The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8\u2009+\u2009T Cell Effector Function. Cancer Cell 26:923\u2013937. https:\/\/doi.org\/10.1016\/j.ccell.2014.10.018","journal-title":"Cancer Cell"},{"key":"12209_CR69","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/82_2014_372","volume":"381","author":"D Christie","year":"2014","unstructured":"Christie D, Zhu J (2014) Transcriptional regulatory networks for CD4 T cell differentiation. Curr Top Microbiol Immunol 381:125\u2013172. https:\/\/doi.org\/10.1007\/82_2014_372","journal-title":"Curr Top Microbiol Immunol"},{"key":"12209_CR70","doi-asserted-by":"publisher","first-page":"1457189","DOI":"10.3389\/fimmu.2024.1457189","volume":"15","author":"J Ge","year":"2024","unstructured":"Ge J, Yin X, Chen L (2024) Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations. Front Immunol 15:1457189. https:\/\/doi.org\/10.3389\/fimmu.2024.1457189","journal-title":"Front Immunol"},{"key":"12209_CR71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41388-025-03458-1","volume":"44","author":"J Saravia","year":"2025","unstructured":"Saravia J, Chi H (2025) Immunometabolism of regulatory T cells in cancer. Oncogene 2025 44:25. https:\/\/doi.org\/10.1038\/s41388-025-03458-1","journal-title":"Oncogene 2025"},{"key":"12209_CR72","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin A, Gil-de-G\u00f3mez L, Dahiya S et al (2017) Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments. Cell Metab 25:1282\u20131293e7. https:\/\/doi.org\/10.1016\/j.cmet.2016.12.018","journal-title":"Cell Metab"},{"key":"12209_CR73","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.4110\/in.2026.26.e10","volume":"26","author":"D Kim","year":"2026","unstructured":"Kim D, Lee N, Ha SJ (2026) Regulatory T Cell Heterogeneity in the Steady State and Tumor. Immune Netw 26:e10. https:\/\/doi.org\/10.4110\/in.2026.26.e10","journal-title":"Immune Netw"},{"key":"12209_CR74","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","volume":"37","author":"DH Munn","year":"2016","unstructured":"Munn DH, Mellor AL (2016) IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance. Trends Immunol 37:193\u2013207. https:\/\/doi.org\/10.1016\/j.it.2016.01.002","journal-title":"Trends Immunol"},{"key":"12209_CR75","doi-asserted-by":"publisher","first-page":"1729690","DOI":"10.3389\/fimmu.2025.1729690","volume":"16","author":"F Getachew","year":"2025","unstructured":"Getachew F, Hu J, Benamar M (2025) Metabolic regulation of regulatory T cells: mechanisms, heterogeneity, and implications in disease. Front Immunol 16:1729690. https:\/\/doi.org\/10.3389\/fimmu.2025.1729690","journal-title":"Front Immunol"},{"key":"12209_CR76","doi-asserted-by":"publisher","unstructured":"Zhang A, Fan T, Liu Y et al (2024) Regulatory T cells in immune checkpoint blockade antitumor therapy. Mol Cancer 23. https:\/\/doi.org\/10.1186\/s12943-024-02156-y","DOI":"10.1186\/s12943-024-02156-y"},{"key":"12209_CR77","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2017.07.024","volume":"170","author":"SC Wei","year":"2017","unstructured":"Wei SC, Levine JH, Cogdill AP et al (2017) Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade. Cell 170:1120\u20131133e17. https:\/\/doi.org\/10.1016\/j.cell.2017.07.024","journal-title":"Cell"},{"key":"12209_CR78","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","volume":"10","author":"Y Kieffer","year":"2020","unstructured":"Kieffer Y, Hocine HR, Gentric G et al (2020) Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer. Cancer Discov 10:1330\u20131351. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1384","journal-title":"Cancer Discov"},{"key":"12209_CR79","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-med-043024-123559","volume":"77","author":"M Navarrete","year":"2025","unstructured":"Navarrete M, Costoya C, Galvez-Cancino F et al (2025) Regulatory T Cell Depletion in Cancer: Challenges, Opportunities, and Future Directions for Antibody Development. Annu Rev Med 77:239\u2013251. https:\/\/doi.org\/10.1146\/annurev-med-043024-123559","journal-title":"Annu Rev Med"},{"key":"12209_CR80","doi-asserted-by":"publisher","unstructured":"Roider HG, Hoff S, Tseng SY et al (2024) Selective depletion of tumor-infiltrating regulatory T cells with BAY 3375968, a novel Fc-optimized anti-CCR8 antibody. Clin Exp Med 24. https:\/\/doi.org\/10.1007\/s10238-024-01362-8","DOI":"10.1007\/s10238-024-01362-8"},{"key":"12209_CR81","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/14737140.2024.2379914","volume":"24","author":"GS Silva","year":"2024","unstructured":"Silva GS, Kim EJ, Barta SK, Chung J (2024) Immune-related adverse events associated with mogamulizumab: a comprehensive review of the literature. Expert Rev Anticancer Ther 24:819\u2013827. https:\/\/doi.org\/10.1080\/14737140.2024.2379914","journal-title":"Expert Rev Anticancer Ther"},{"key":"12209_CR82","doi-asserted-by":"publisher","unstructured":"Yang Y, Zhu L, Xu Y et al (2025) The progress and prospects of targeting the adenosine pathway in cancer immunotherapy. Biomarker Research 2025 13:1 13:75-. https:\/\/doi.org\/10.1186\/s40364-025-00784-0","DOI":"10.1186\/s40364-025-00784-0"},{"key":"12209_CR83","doi-asserted-by":"publisher","unstructured":"Ager CR, Obradovic A, McCann P et al (2025) Fc-enhanced anti-CTLA-4 depletes tumor-infiltrating regulatory T cells to augment immune effects of androgen ablation in high-risk prostate cancer. medRxiv 2024.09.09.24313308. https:\/\/doi.org\/10.1101\/2024.09.09.24313308","DOI":"10.1101\/2024.09.09.24313308"},{"key":"12209_CR84","doi-asserted-by":"publisher","first-page":"2497171","DOI":"10.1080\/2162402X.2025.2497171","volume":"14","author":"R Wang","year":"2025","unstructured":"Wang R, Xu J, Cheng S et al (2025) TNFR2\/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8\u2009+\u2009T cell function. Oncoimmunology 14:2497171. https:\/\/doi.org\/10.1080\/2162402X.2025.2497171","journal-title":"Oncoimmunology"},{"key":"12209_CR85","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1016\/j.ymthe.2024.10.013","volume":"32","author":"M Venkatachalapathy","year":"2024","unstructured":"Venkatachalapathy M (2024) Targeting intratumoral Tregs: The promise of CD25\u00d7TIGIT bispecific antibodies in solid tumor therapy. Mol Ther 32:3758. https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.013","journal-title":"Mol Ther"},{"key":"12209_CR86","doi-asserted-by":"publisher","first-page":"1345838","DOI":"10.3389\/fimmu.2024.1345838","volume":"15","author":"J Liu","year":"2024","unstructured":"Liu J, Zhang B, Zhang G, Shang D (2024) Reprogramming of regulatory T cells in inflammatory tumor microenvironment: can it become immunotherapy turning point? Front Immunol 15:1345838. https:\/\/doi.org\/10.3389\/fimmu.2024.1345838","journal-title":"Front Immunol"},{"key":"12209_CR87","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng C, Zheng L, Yoo JK et al (2017) Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell 169:1342\u20131356e16. https:\/\/doi.org\/10.1016\/j.cell.2017.05.035","journal-title":"Cell"},{"key":"12209_CR88","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24:541\u2013550. https:\/\/doi.org\/10.1038\/s41591-018-0014-x","journal-title":"Nat Med"},{"key":"12209_CR89","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1002\/jcp.25016","volume":"230","author":"D Wolf","year":"2015","unstructured":"Wolf D, Sopper S, Pircher A et al (2015) Treg(s) in Cancer: Friends or Foe? J Cell Physiol 230:2598\u20132605. https:\/\/doi.org\/10.1002\/jcp.25016","journal-title":"J Cell Physiol"},{"key":"12209_CR90","doi-asserted-by":"publisher","unstructured":"Wang Y, Li J, Nakahata S, Iha H (2024) Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms25137346","DOI":"10.3390\/ijms25137346"},{"key":"12209_CR91","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","volume":"16","author":"Y Togashi","year":"2019","unstructured":"Togashi Y, Shitara K, Nishikawa H (2019) Regulatory T cells in cancer immunosuppression - implications for anticancer therapy. Nat Rev Clin Oncol 16:356\u2013371. https:\/\/doi.org\/10.1038\/s41571-019-0175-7","journal-title":"Nat Rev Clin Oncol"},{"key":"12209_CR92","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41588-025-02193-3","volume":"57","author":"MF de Oliveira","year":"2025","unstructured":"de Oliveira MF, Romero JP, Chung M et al (2025) High-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer. Nat Genet 2025 57:6. https:\/\/doi.org\/10.1038\/s41588-025-02193-3","journal-title":"Nat Genet 2025"},{"key":"12209_CR93","doi-asserted-by":"publisher","unstructured":"Song X, Zhu Y, Geng W et al (2025) Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma. J Immunother Cancer 13. https:\/\/doi.org\/10.1136\/jitc-2024-010183","DOI":"10.1136\/jitc-2024-010183"},{"key":"12209_CR94","doi-asserted-by":"publisher","unstructured":"Mortezaee K (2026) Regulatory T Cell Metabolism in Cancer. Immunology 177. https:\/\/doi.org\/10.1111\/imm.70096","DOI":"10.1111\/imm.70096"},{"key":"12209_CR95","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/cells15030228","volume":"15","author":"K Subedi","year":"2026","unstructured":"Subedi K, Parajuli N, Solone XK et al (2026) Unraveling the Epigenetic Regulation of Regulatory T Cells in Cancer Immunity. Cells 15:228. https:\/\/doi.org\/10.3390\/cells15030228","journal-title":"Cells"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12209-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12209-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12209-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:27:17Z","timestamp":1782217637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12209-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12209"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12209-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"During the preparation of this work the authors used ChatGPT to improve language and readability. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}}],"article-number":"985"}}